1 November 2017 1.00 pm - 2.00 pm Australia/Sydney
The TRANSFUSE Study was a randomized controlled trial that explored does transfusion of freshest available RBC's in critically ill patients compared to standard care, decrease patient mortality?
The results and implications of this multicentre study are discussed by Dr Phillip Mondy one of the authors of the study.
Presenter: Dr Philip Mondy, Medical Specialist, Clinical Services and Research, Blood Service.
8 November 2017 01:30pm - 02:30pm - Australia/Adelaide
This session provides an overview of possible clinical errors during a blood transfusion.
|Presenter:||Dr Beveleigh Quested, Transfusion Education Manager, Blood Service.|
This session outlines the GCUH targeted coagulation management strategy and its implementation using case study examples. The rationale, the evidence and the technology is highlighted.
|Presenter:||Dr James Winearls, Consultant Intensivist, Gold Coast University Hospital.|
Since 1967, the lives of countless babies have been saved by the pioneering Rh Program - and to date, over three million doses of anti-D have been given to Rh negative women.
The program provides plasma collected from blood donors with anti-D for production of anti-D immunoglobulin for treatment of RhD negative women with babies at risk of haemolytic disease of the fetus and newborn (HDFN).
The following two presentations commemorate 50 years of the Anti-D Program and look at the prevention of Rh HDFN.
|Presenters:||Jessie Wallis, RhD Program Coordinator, South Australia, Australian Red Cross Blood Service.|
|Dr Amanda Thomson, Haematologist/Transfusion Medicine Specialist, Australian Red Cross Blood Service.|
16 August 2017 12:30pm - 01:30pm - Australia/Sydney
The research and development team at the Blood Service conducts leading-edge research to find improved ways to process, store and distribute blood components. This session explores data linkage and provides an update on a data linkage study in maternity.
|Presenter:||Professor David Irving, Director, Research and Development, Blood Service.|
12 July 2017 12:30pm - 01:30pm - Australia/Sydney
Hepatitis C is transmissible by transfusion. The Blood Service has tested all donated blood and blood product for hepatitis C virus RNA and antibodies since 1990. Another viral infectious disease, Zika virus, made international news headlines in 2016 due to its largest ever documented outbreak in several countries. Zika virus has also been shown to be transmissible by transfusion. Evidence that Zika is occasionally responsible for severe outcomes including birth defects and Guillain-Barré Syndrome is now compelling. This session provides an overview of Hepatitis C and Zika virus, their transmission, management and related concerns about safety of blood transfusion.
|Presenter:||Dr George Kotsiou, National Donor and Product Safety Specialist, Blood Service.|
10 May 2017 01:30pm - 02:30pm - Australia/Sydney
How I get the best out of a platelet transfusion.
|Presenter:||Dr Richard Kaufman, Associate Professor of Pathology, Harvard Medical School and Medical Director of Adult Transfusion Medicine Service, Brigham and Women's Hospital, United States of America.|
29 March 2017 01:30pm - 02:30pm - Australia/Melbourne
This session focuses on the immunology as one of the new dimensions in providing compatible platelets. The background science and testing processes are discussed followed by how it is applied to patient care in the renal setting.
Rhonda Holdsworth, National Manager, Transplantation and Immunogenetics Services, Blood Service
Cathie Hart, Deputy Manager, VTIS, Blood Service.
2 November 2016 01:30pm - 02:30pm - Australia/Sydney
Volunteer non-remunerated blood donors (VNRBD) are a key plank in Australia's safe blood supply. Within the Asia Pacific region a range of donor types such as family replacement donors provide blood products. Recruiting and retaining VNRBD donors is an ongoing issue to ensure a safe blood supply.
|Presenter:||Mr Ben Scales, Acting Marketing Director, Blood Service.|
13 October 2016 01:00pm - 02:00pm - Australia/Melbourne
Retrieval medicine has changed the way trauma patients haemostasis is managed and their outcomes. Data, the golden hour, helicopters, paramedics and transfusion support are part of retrieval medicine.
|Presenters:||Dr Chris Hogan, Medical Director, Pathology Services, Blood Service, Haematologist, Royal Melbourne Hospital.|
|Mr Murray Barkmeyer, Paramedic, Air Ambulance Victoria|
21 September 2016 01:30pm - 02:30pm - Australia/Melbourne
Australia relies on retaining and recruiting volunteer blood donors for an adequate blood supply. Research into understanding motivation for donating, and how to recruit and maintain donors is vital.
|Presenters:||A/Prof Barbara Masser, School of Psychology, University of Queensland, Hon. PrincipalResearch Fellow, Blood Service|
|Ms Amanda Thijsen, Senior Research Assistant, Donor Research, Blood Service.|
|Dr Alison Carver, Senior Research Fellow, Donor Research, Blood Service.|
14 September 2016 01:30pm - 02:30pm - Australia/Melbourne
A sustainable blood supply depends on an intricate balance of unpaid donors' gifts with patients' needs supported by an efficient and reliable manufacturer of quality blood and blood products. This session explores some of the issues associated with blood supply and demand while considering the patients' needs.
|Presentation 1: Demand management - Blending Science and Art.|
Presenter: Mark Lake, Demand Manager, Blood Service.
|Presentation 2: Inventory oversight - Demand vs Supply.|
Presenter: David McKie, Supply Chain Planning Manager, Blood Service.
|Presentation 3: The rise and rise of plasma and why 637 tonnes is still not enough.|
Presenter: Richard Walsh, Plasma Program Project Manager, Blood Service.
8 August 2016 12:00pm - 01:00pm - Australia/Darwin
This session explores issues related to Transfusion in the Northern Territory and transfusion related support issues for remote and isolated communities.
Presentation 1:Transfusion medicine services in the top end of Australia
Presenter: Kylie Wright, Senior Transfusion Scientist, Royal Darwin Hospital
|Presentation 2:Alice Springs Hospital|
Presenter: Tracy O'Brien, Transfusion Scientist, Alice Springs Hospital
|Presentation 3: NT Transfusion Clinical Practice|
Presenter: Julie Domanski, Transfusion Clinical Nurse, Royal Darwin Hospital
20 July 2016 03:00pm - 04:00pm - Australia/Sydney
This session identifies the occurrence of transfusion related unwanted events, to increase the safety, efficacy and efficiency of blood transfusion, covering all activities of the transfusion chain from donor to recipient.
|Presenters:||Dr Paula Bolton-Maggs, Medical Director, Serious Hazards of Transfusion Scheme (SHOT), NHSBT, UK.|
|Justine O'Donovan, National Donor Haemovigilance Officer, Blood Service.|
15 June 2016 07:45am - 08:45am - Australia/Brisbane
This session presents and discusses the National Blood Authority Module 6 Patient Blood Management Paediatric and Neonatal Guidelines.
|Presenter:||A/Prof Helen Liley, Neonatal Paediatrician, Hon Senior Fellow, Mater Research|
24 May 2016
Following the first case of vCJD in the UK in 1996 there was heightened concern of the possibility of transfusion transmission of the causative prion. Blood Services around the world introduced deferrals for UK residents. Several attempts to develop a robust screening assay for prions in blood of appropriate sensitivity and specificity have not yielded a robust enough test.
|Presenter:||Dr Anthony Keller, National Donor and Product Safety Specialist, Blood Service.|
18 May 2016 01:30pm - 02:30pm - Australia/Sydney
The Blood Service's Research and Development Unit conducts research and technology evaluations that have the potential to improve blood product quality and safety, operational efficiency and donor well-being to deliver leading edge, high quality blood and blood products to improve patient outcomes.
|Presenters:||Dr Lacey Johnson, Principal Research Fellow, Research and Development, Blood Service.|
|Dr Celine Loh, Research Fellow, Research and Development, Blood Service.|
11 May 2016 01:30pm - 02:30pm - Australia/Brisbane
Gene Sequencing technology and developments in microarray platforms are already having an impact on the ability to provide compatible matched red cells for patients in the 21st century. This session outlines the technology changes going forward as well as solving some mysteries from the past and assisting in the management of clinical challenges of today.
|Presenters:||Jenny Morrison, Scientist, Red Cell Reference, Blood Service.|
|Dr Elizna Schoeman, Senior Research Assistant, Research and Development, Blood Service.|
|Dr Catherine Hyland, Principal Research Fellow, Research and Development, Blood Service.|
13 April 2016 10.00am - 11:00am - Australia/Perth
Donor selection and screening is a vital step in safe transfusion practice. Ongoing assessment of a range of donor factors such as travel, medical tourism and social practices such as tattoos require an ongoing vigilance and consideration by the Blood Service.
|Presenter:||Dr Veronica Hoad, Public Health Physician, Clinical Services and Research, Blood Service.|
9 March 2016 01:30pm - 2:30pm - Australia/Melbourne
Transfusion support for patients with renal disease requires expert medical and scientific involvement while they are managed on transplantation waiting lists and are undergoing dialysis. Optimising haemostasis as well as avoiding development of further HLA antibodies requires dialysis transplantation, transfusion medicine and patient blood management expertise.
|Presenters:||A/Prof Shlomo Cohney, Transplant Physician, University of Melbourne & Monash University|
|Dr Jeremy McComish, Clinical Immunologist, Allergist and Immunopathologist, Blood Service.|